ExodusPoint Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-199,358
Closed -$634K 1471
2025
Q1
$634K Buy
199,358
+185,842
+1,375% +$591K 0.01% 997
2024
Q4
$72K Buy
+13,516
New +$72K ﹤0.01% 1294
2022
Q2
Sell
-25,563
Closed -$42K 1958
2022
Q1
$42K Buy
+25,563
New +$42K ﹤0.01% 2012
2020
Q1
Sell
-22,861
Closed -$124K 1116
2019
Q4
$124K Buy
+22,861
New +$124K ﹤0.01% 1352